Catheter Precision, Inc. announced that its innovative 3D Mapping system will be highlighted at several electrophysiology conferences this fall. Most recently, VIVO was highlighted at the 19th Congresso Nazionale Associazione Italiana di Aritmologia e Cardiostimolazione in Bologna, Italy from September 21-22. In addition to VIVO, Catheter Precision will be present at other conferences also highlighting their newly introduced product, LockeT, a venous stasis closure device.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5656 USD | +2.65% | +3.04% | +39.90% |
May. 06 | Catheter Precision, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 01 | Catheter Precision, Inc. Appoints Marie-Claude Jacques as Chief Commercial Officer | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.93% | 4.17M | |
+7.88% | 219B | |
+6.87% | 183B | |
+14.84% | 136B | |
+26.83% | 107B | |
-1.63% | 63.07B | |
+7.76% | 52.55B | |
+12.37% | 51.28B | |
+1.58% | 41.21B | |
+4.85% | 36.43B |
- Stock Market
- Equities
- VTAK Stock
- News Catheter Precision, Inc.
- Catheter Precision Showcasing Its Innovative 3D Mapping System